Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Pulse Biosciences ( (PLSE) ) has provided an announcement.
On October 10, 2025, Pulse Biosciences announced the results of its first-in-human feasibility study using the nPulse Cardiac Surgical System at the European Association for Cardio-Thoracic Surgery Annual Meeting. The study, which involved 44 patients, demonstrated high success rates in pulmonary vein isolation and posterior box isolation without severe adverse events, indicating the potential for the nPulse system to enhance cardiac surgical ablation for atrial fibrillation.
The most recent analyst rating on (PLSE) stock is a Buy with a $22.00 price target. To see the full list of analyst forecasts on Pulse Biosciences stock, see the PLSE Stock Forecast page.
Spark’s Take on PLSE Stock
According to Spark, TipRanks’ AI Analyst, PLSE is a Neutral.
Pulse Biosciences receives a low overall score due to persistent financial challenges such as continuous losses and cash burn. While technical indicators show some positive momentum, the valuation remains unattractive due to negative earnings. The earnings call provided a balanced view with notable advancements in technology and strengthened finances, but increased operational costs remain a concern. The CFO appointment is a positive strategic move but does not significantly affect the overall score.
To see Spark’s full report on PLSE stock, click here.
More about Pulse Biosciences
Pulse Biosciences is a novel bioelectric medicine company focused on health innovation, aiming to improve the quality of life for patients. The company’s proprietary nPulse technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. They are actively developing this technology for the treatment of atrial fibrillation and other markets where it could significantly impact healthcare.
Average Trading Volume: 185,182
Technical Sentiment Signal: Strong Buy
Current Market Cap: $1.34B
Learn more about PLSE stock on TipRanks’ Stock Analysis page.